News

CHINA: NMPA Issues the Draft of "Measures for the Supervision and Administration of the Local Authorization Agent for Imported Medical Device" - October 2018

CHINA: NMPA Issues the Draft of "Measures for the Supervision and Administration of the Local Authorization Agent for Imported Medical Device" - October 2018

  • 2020-02-12 14:21:58

Last August, NMPA has issued a draft entitled “Measures for the Supervision and Administration of the Local Authorization Agent for Imported Medical Device” in order to ensure the safety and effectiveness thereof. The draft was also aimed at regulating the behavior of local authorized agents of imported medical devices.

More
CHINA: NMPA Issued the Draft for UDI Rules of Medical Device- October 2018

CHINA: NMPA Issued the Draft for UDI Rules of Medical Device- October 2018

  • 2020-02-12 14:21:01

In order to reinforce the supervision and management of the development, production, operation and use of medical devices, NMPA (National Medical Product Administration) has issued the “Draft of UDI Rules for Medical Device” at the end of August with the primary objective of establishing a unique identification system (UDI) for medical devices. This regulation applies to medical devices that are sold and used in China.

More
CHINA: CFDA Officially Changed the English Name to NMPA – September, 2018

CHINA: CFDA Officially Changed the English Name to NMPA – September, 2018

  • 2020-02-12 15:55:53

On August 29, a new notice from the department of drug registration has revealed that CFDA has changed to its official English name to ‘National Medical Product Administration (NMPA)’ which was also adopted by the medical device registration system. It can be seen that NMPA is already an officially recognized English name.

More
CHINA: CNDA has Released a New Catalogue of Medical Devices to Be Exempted from Clinical Trials (Draft) – July 2018

CHINA: CNDA has Released a New Catalogue of Medical Devices to Be Exempted from Clinical Trials (Draft) – July 2018

  • 2020-02-14 03:59:43

In early June, CNDA had issued a draft consisting of the fourth batch of medical device catalogues to be exempted from clinical trials along with the revisions of the first three batches of catalogues, in able to catch up with the upcoming classification to be implemented in July. In this regard, CNDA is currently accepting comments from the public until the end of June 2018.

More